Scott Kinlay, Ph.D., M.B.,B.S.
This page shows the publications Scott Kinlay has written about Cost-Benefit Analysis.
Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry. J Invasive Cardiol. 2019 01; 31(1):1-9.
Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med. 1996 Jan 01; 124(1 Pt 1):16-20.
The cost-effectiveness of different blood-cholesterol-lowering strategies in the prevention of coronary heart disease. Aust J Public Health. 1994 Mar; 18(1):105-10.
The validity of estimating heart disease reduction from a Framingham logistic equation. J Clin Epidemiol. 1992 May; 45(5):553-60.
High cholesterol levels: is mass screening the best option? Med J Aust. 1988 Jun 20; 148(12):635-7.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.